According to INmune Bio's latest financial reports the company's current EPS (TTM) is -ยฃ1.40. In 2022 the company made an earnings per share (EPS) of -ยฃ1.18 an increase over its 2021 EPS that were of -ยฃ1.46.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -ยฃ1.45 | |
2022 | -ยฃ1.18 | -19.15% |
2021 | -ยฃ1.46 | 86.14% |
2020 | -ยฃ0.78 | 34.67% |
2019 | -ยฃ0.58 | -32.36% |
2018 | -ยฃ0.86 | 1396.12% |
2017 | -ยฃ0.05745 | 199.64% |
2016 | -ยฃ0.01917 |